8Gillberg PG, Sundquist S, Nilvebrant L. Comparison of the invitro and vivo profiles of tolterodine with those if subtypeselective muscarinic receptors anagonists. EurJ Pharmacol 1998; 349(2): 285-292. 被引量：1
9Chapple CR, Smith D. The pathophysiological changes in the bladder obstructed by benign prostatic hyperplasia. BrJUrol 1994; 73(2): 117-123. 被引量：1
10Blok BF. Central pathways controlling micturition and urinary continence. Urology 2002; 59(5 suppl 1): 13-17. 被引量：1
